X4 Pharmaceuticals, Inc. (XFOR)

X4 Pharmaceuticals Revenue

X4 Pharmaceuticals had revenue of $1.97M in the quarter ending June 30, 2025, with 250.44% growth. This brings the company's revenue in the last twelve months to $32.77M, up 5,721.31% year-over-year. In the year 2024, X4 Pharmaceuticals had annual revenue of $2.56M.

• Revenue (ttm): $32.77M
• Revenue Growth: +5,721.31%
• P/S Ratio: 0.62
• Revenue / Employee: $229,189
• Employees: 143
• Market Cap: 33.43M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.56M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	3.00M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.